Nanopolymeric micelle effect on the transdermal permeability, the bioavailability and gene expression of plasmid

Yaw Chong Tong, Ting Yu Yu, Shwu Fen Chang, Jiahorng Liaw

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This study attempts to investigate the transdermal permeability, the bioavailability and gene expression of plasmid formulated with nonionic poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles (PM). Dynamic light scattering (DLS) and atomic force microscopy (AFM) were used to analyze the PM formulated pCMV-Lac Z (P/PM) containing the gene for β-galactosidase (β-Gal) driven by cytomegalovirus early promoter. Franz diffusion cell was used for in vitro transdermal permeability analysis. Real-time PCR was used to quantify the permeated plasmid in vitro and in vivo. β-Gal activity assay was performed to evaluate transgene expression in vivo. The size of P/PM was ∼50 nm with round shape. PM significantly enhanced the in vitro transdermal permeability of plasmid in a direction- and temperature-dependent manner. Following transdermal application of P/PM, higher area under the curve (AUC P/PM: 98.34 hng/mL) and longer half-life of plasmid were detected compared with that of plasmid alone (AUC P: 10.12 hng/mL). Additionally, the β-Gal activity was significantly increased in skin, stomach, brain and spinal cord at both 48 and 72 h after P/PM application and in testis and spleen at 72 h postapplication. In conclusion, PM formulation enhanced the permeation of plasmid through skin into blood circulation, increasing its absorption and the transgene expression in various tissues.

Original languageEnglish
Pages (from-to)111-120
Number of pages10
JournalMolecular Pharmaceutics
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

Micelles
Biological Availability
Permeability
Plasmids
Gene Expression
Area Under Curve
Transgenes
Galactosidases
Skin
Blood Circulation
Atomic Force Microscopy
Cytomegalovirus
Half-Life
Testis
Real-Time Polymerase Chain Reaction
Spinal Cord
Stomach
Spleen
Temperature
Brain

Keywords

  • nanocarrier
  • polymeric micelles
  • transdermal permeability

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Nanopolymeric micelle effect on the transdermal permeability, the bioavailability and gene expression of plasmid. / Tong, Yaw Chong; Yu, Ting Yu; Chang, Shwu Fen; Liaw, Jiahorng.

In: Molecular Pharmaceutics, Vol. 9, No. 1, 01.01.2012, p. 111-120.

Research output: Contribution to journalArticle

@article{6f2764462dec4695950651a64326a4b1,
title = "Nanopolymeric micelle effect on the transdermal permeability, the bioavailability and gene expression of plasmid",
abstract = "This study attempts to investigate the transdermal permeability, the bioavailability and gene expression of plasmid formulated with nonionic poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles (PM). Dynamic light scattering (DLS) and atomic force microscopy (AFM) were used to analyze the PM formulated pCMV-Lac Z (P/PM) containing the gene for β-galactosidase (β-Gal) driven by cytomegalovirus early promoter. Franz diffusion cell was used for in vitro transdermal permeability analysis. Real-time PCR was used to quantify the permeated plasmid in vitro and in vivo. β-Gal activity assay was performed to evaluate transgene expression in vivo. The size of P/PM was ∼50 nm with round shape. PM significantly enhanced the in vitro transdermal permeability of plasmid in a direction- and temperature-dependent manner. Following transdermal application of P/PM, higher area under the curve (AUC P/PM: 98.34 hng/mL) and longer half-life of plasmid were detected compared with that of plasmid alone (AUC P: 10.12 hng/mL). Additionally, the β-Gal activity was significantly increased in skin, stomach, brain and spinal cord at both 48 and 72 h after P/PM application and in testis and spleen at 72 h postapplication. In conclusion, PM formulation enhanced the permeation of plasmid through skin into blood circulation, increasing its absorption and the transgene expression in various tissues.",
keywords = "nanocarrier, polymeric micelles, transdermal permeability",
author = "Tong, {Yaw Chong} and Yu, {Ting Yu} and Chang, {Shwu Fen} and Jiahorng Liaw",
year = "2012",
month = "1",
day = "1",
doi = "10.1021/mp200342h",
language = "English",
volume = "9",
pages = "111--120",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Nanopolymeric micelle effect on the transdermal permeability, the bioavailability and gene expression of plasmid

AU - Tong, Yaw Chong

AU - Yu, Ting Yu

AU - Chang, Shwu Fen

AU - Liaw, Jiahorng

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This study attempts to investigate the transdermal permeability, the bioavailability and gene expression of plasmid formulated with nonionic poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles (PM). Dynamic light scattering (DLS) and atomic force microscopy (AFM) were used to analyze the PM formulated pCMV-Lac Z (P/PM) containing the gene for β-galactosidase (β-Gal) driven by cytomegalovirus early promoter. Franz diffusion cell was used for in vitro transdermal permeability analysis. Real-time PCR was used to quantify the permeated plasmid in vitro and in vivo. β-Gal activity assay was performed to evaluate transgene expression in vivo. The size of P/PM was ∼50 nm with round shape. PM significantly enhanced the in vitro transdermal permeability of plasmid in a direction- and temperature-dependent manner. Following transdermal application of P/PM, higher area under the curve (AUC P/PM: 98.34 hng/mL) and longer half-life of plasmid were detected compared with that of plasmid alone (AUC P: 10.12 hng/mL). Additionally, the β-Gal activity was significantly increased in skin, stomach, brain and spinal cord at both 48 and 72 h after P/PM application and in testis and spleen at 72 h postapplication. In conclusion, PM formulation enhanced the permeation of plasmid through skin into blood circulation, increasing its absorption and the transgene expression in various tissues.

AB - This study attempts to investigate the transdermal permeability, the bioavailability and gene expression of plasmid formulated with nonionic poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles (PM). Dynamic light scattering (DLS) and atomic force microscopy (AFM) were used to analyze the PM formulated pCMV-Lac Z (P/PM) containing the gene for β-galactosidase (β-Gal) driven by cytomegalovirus early promoter. Franz diffusion cell was used for in vitro transdermal permeability analysis. Real-time PCR was used to quantify the permeated plasmid in vitro and in vivo. β-Gal activity assay was performed to evaluate transgene expression in vivo. The size of P/PM was ∼50 nm with round shape. PM significantly enhanced the in vitro transdermal permeability of plasmid in a direction- and temperature-dependent manner. Following transdermal application of P/PM, higher area under the curve (AUC P/PM: 98.34 hng/mL) and longer half-life of plasmid were detected compared with that of plasmid alone (AUC P: 10.12 hng/mL). Additionally, the β-Gal activity was significantly increased in skin, stomach, brain and spinal cord at both 48 and 72 h after P/PM application and in testis and spleen at 72 h postapplication. In conclusion, PM formulation enhanced the permeation of plasmid through skin into blood circulation, increasing its absorption and the transgene expression in various tissues.

KW - nanocarrier

KW - polymeric micelles

KW - transdermal permeability

UR - http://www.scopus.com/inward/record.url?scp=84855437923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855437923&partnerID=8YFLogxK

U2 - 10.1021/mp200342h

DO - 10.1021/mp200342h

M3 - Article

C2 - 22142416

AN - SCOPUS:84855437923

VL - 9

SP - 111

EP - 120

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 1

ER -